EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
40.25 EUR
0 (0%)
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 10 industry peers in the Health Care Technology industry. While EQS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
EQS had positive earnings in each of the past 5 years.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
EQS has a better Return On Assets (8.84%) than 70.00% of its industry peers.
EQS has a Return On Equity of 15.79%. This is in the better half of the industry: EQS outperforms 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 12.70%, EQS belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
The Profit Margin of EQS (16.15%) is better than 80.00% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS's Operating Margin of 19.80% is amongst the best of the industry. EQS outperforms 90.00% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 68.81%, EQS is doing worse than 70.00% of the companies in the same industry.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EQS is creating some value.
Compared to 1 year ago, EQS has about the same amount of shares outstanding.
Compared to 5 years ago, EQS has more shares outstanding
The debt/assets ratio for EQS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.84 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS's Altman-Z score of 3.84 is fine compared to the rest of the industry. EQS outperforms 70.00% of its industry peers.
The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.98, EQS is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
The Debt to Equity ratio of EQS (0.09) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.84 |
ROIC/WACC1.14
WACC11.17%
2.3 Liquidity
EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a worse Current ratio (1.29) than 60.00% of its industry peers.
A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
EQS's Quick ratio of 1.20 is on the low side compared to the rest of the industry. EQS is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.63% on average per year.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.84, EQS is valued correctly.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of EQS to the average of the S&P500 Index (25.83), we can say EQS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.40, the valuation of EQS can be described as correct.
80.00% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (32.68), we can say EQS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.84 | ||
| Fwd PE | 12.4 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.44 | ||
| EV/EBITDA | 8.25 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)3.29
EPS Next 2Y19.01%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.11%, EQS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.42, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.75% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.75%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPA:EQS (11/7/2025, 7:00:00 PM)
40.25
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap610.59M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts83.33
Price Target49.98 (24.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.01%
PT rev (3m)-14.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.84 | ||
| Fwd PE | 12.4 | ||
| P/S | 2.72 | ||
| P/FCF | 16.44 | ||
| P/OCF | 12.65 | ||
| P/B | 2.66 | ||
| P/tB | 7.64 | ||
| EV/EBITDA | 8.25 |
EPS(TTM)2.39
EY5.94%
EPS(NY)3.25
Fwd EY8.07%
FCF(TTM)2.45
FCFY6.08%
OCF(TTM)3.18
OCFY7.9%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)0.9
PEG (5Y)3.29
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.84 |
F-Score7
WACC11.17%
ROIC/WACC1.14
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 18.72% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.